IRON - CIK 0001816736
The table below shows Disc Medicine, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $170.64M | $96.67M | $69.26M | $33.44M | $25.17M | $28.17M |
| SG&A | $65.38M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $33.05M |
| $21.86M |
| - |
| - |
| - |
| Operating income | -$236.02M | -$129.72M | -$91.13M | -$47.48M | -$30.93M | -$34.04M |
| Income tax | $361.00K | $355.00K | $99.00K | $0.00 | - | - |
| Net income | -$212.18M | -$109.36M | -$76.43M | -$46.83M | -$35.97M | -$40.84M |
| EPS (diluted) | -$6.01 | -$3.96 | -$3.42 | -$45.05 | -$40.95 | - |